000			01985cam a2200373 i 4500
999			_c26382 _d26381
001			17921915
003			SA-RiNAUS
005			20190414075312.0
008			131029t20142014ne a b 001 0 eng
020			_a9780123820303 (alk. paper)
040			_aDLC _beng _cDLC _erda _dDLC
082	0	0	_223 _a615.19 _bS R O
100	1		_aSilverman, Richard B., _eauthor. _92321
245	1	4	_aThe organic chemistry of drug design and drug action.
250			_aThird edition / _bRichard B. Silverman, Northwestern University, Department of Chemistry, Department of Molecular Biosciences, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Evanston, Illinois, USA, Mark W. Holladay, Ambit Biosciences Corporation, Departments of Drug Discovery and Medicinal Chemistry, San Diego, California, USA.
264		1	_aAmsterdam ; _aBoston : _bElsevier/AP, Academic Press, is an imprint of Elsevier, _c[2014]
300			_axviii, 517 pages : _billustrations (some color) ; _c29 cm
500			_aشراء معرض القاهرة للكتاب 2019
504			_aIncludes bibliographical references and index.
505	0		_aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
650		0	_aPharmaceutical chemistry. _92189
650		0	_aBioorganic chemistry. _92322
650		0	_aMolecular pharmacology. _92323
650		0	_aDrugs _xDesign. _92311
700	1		_aHolladay, Mark W., _eauthor. _92324
942			_2ddc _cBK